J. Schubert

Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany

L. Wojtecki, L. Grabenhenrich, J. Rupp, 2023, BMC Infectious Diseases.

Long Term Safety and Efficacy of Sustained Eculizumab Treatment In Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

J. Maciejewski, L. Luzzatto, J. Szer, 2010 .

Analysis of everolimus starting dose as prognostic marker in HR+ mBC patients treated with everolimus (EVE) + exemestane (EXE): Results of the 3rd interim analysis of the non-interventional trial BRAWO.

P. Fasching, F. Schuetz, H. Tesch, 2017 .

Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis

N. Kröger, A. Zander, R. Brand, 2011 .

RIBECCA: A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole—Results of the first interim analysis.

P. Fasching, T. Fehm, A. Schneeweiss, 2018 .

Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial.

E. Thiel, M. Weller, M. Hummel, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Molecular and Cytogenetic Response After 3 Months of Imatinib Treatment Is Predictive for the Risk of Disease Progression and Death in Newly Diagnosed Chronic Myeloid Leukemia Patients – a Follow-up Analysis of the German CML Study IV

Martin C. Müller, H. Einsele, M. Pfreundschuh, 2011 .

Incorporation of ganglioside analogues into fibroblast cell membranes. A spin-label study.

D. Marsh, K. Sandhoff, G. Schwarzmann, 1983, Biochemistry.